Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cabazitaxel”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03114254
What this trial is testing

A Trial of Cabazitaxel Chemotherapy in Relapsed Locally Advanced &/or Metastatic Carcinoma of the Penis

Who this might be right for
Penile Neoplasm
University Hospitals Bristol and Weston NHS Foundation Trust 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT02202772
What this trial is testing

Intravesical Cabazitaxel, Gemcitabine, and Cisplatin (CGC) in the Treatment Urothelial Carcinoma of the Bladder

Who this might be right for
Urothelial Carcinoma of the Urinary Bladder
Guarionex J. Decastro 51
Early research (Phase 1)Study completedNCT01420250
What this trial is testing

Cabazitaxel With Radiation and Hormone Therapy for Prostate Cancer

Who this might be right for
Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 20
Large-scale testing (Phase 3)Study completedNCT01668459
What this trial is testing

Treatment of Locally Advanced or Metastatic Transitional Cell Carcinoma With Cabazitaxel

Who this might be right for
Transitional Cell Carcinoma
Dr Anjali Zarkar 20
Large-scale testing (Phase 3)Study completedNCT02044354
What this trial is testing

Patient Preference Between Cabazitaxel and Docetaxel in Metastatic Castrate-resistant Prostate Cancer

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Gustave Roussy, Cancer Campus, Grand Paris 195
Post-approval studies (Phase 4)Study completedNCT01649635
What this trial is testing

Study of Cabazitaxel Combined With Prednisone and Prophylaxis of Neutropenia Complications in the Treatment of Patients With Metastatic Castration-resistant Prostate Cancer

Who this might be right for
Prostate Cancer
Sanofi 45
Large-scale testing (Phase 3)Study completedNCT01254279
What this trial is testing

Early Access to Cabazitaxel in Patients With Metastatic Hormone Refractory Prostate Cancer Previously Treated With a Docetaxel-containing Regimen

Who this might be right for
Prostate Cancer Metastatic
Sanofi 984
Testing effectiveness (Phase 2)Study completedNCT04495179
What this trial is testing

AZD4635 With Durvalumab and With Cabazitaxel and Durvalumab in Patients With mCRPC.

Who this might be right for
Progressive Metastatic Castrate-Resistant Prostate Cancer
AstraZeneca 30
Early research (Phase 1)WithdrawnNCT03110588
What this trial is testing

Phase I Trial of PACE for Metastatic Prostate Cancer

Who this might be right for
Metastatic Prostate Cancer
University of Alabama at Birmingham
Large-scale testing (Phase 3)Active Not RecruitingNCT01952223
What this trial is testing

A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse

Who this might be right for
Adenocarcinoma of ProstateProgression of Prostate Cancer
UNICANCER 761
Testing effectiveness (Phase 2)Study completedNCT01751308
What this trial is testing

Safety and Efficacy of Cabazitaxel in Pediatric Patients With Refractory Solid Tumors Including Central Nervous System Tumors

Who this might be right for
Malignant Solid Tumor - Malignant Nervous System Neoplasm
Sanofi 39
Testing effectiveness (Phase 2)WithdrawnNCT02621190
What this trial is testing

Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCs

Who this might be right for
Prostatic Neoplasms
Erasmus Medical Center
Large-scale testing (Phase 3)Active Not RecruitingNCT06691984
What this trial is testing

Phase 3 Study of Xaluritamig vs Cabazitaxel or Second Androgen Receptor-Directed Therapy in Participants With Progressive Metastatic Castration-Resistant Prostate Cancer (XALute)

Who this might be right for
Metastatic Castration-resistant Prostate Cancer
Amgen 707
Testing effectiveness (Phase 2)Study completedNCT01866449
What this trial is testing

Prospective Phase 2 Trial of Cabazitaxel in Patients With Temozolomide Refractory Glioblastoma Multiforme

Who this might be right for
Glioblastoma Multiforme (GBM) WHO Grade IV
University of Ulm 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02703623
What this trial is testing

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Castration Levels of TestosteroneCastration-Resistant Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
M.D. Anderson Cancer Center 196
Testing effectiveness (Phase 2)UnknownNCT04622761
What this trial is testing

Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical Outcome

Who this might be right for
Prostate Cancer
The Clatterbridge Cancer Centre NHS Foundation Trust 120
Testing effectiveness (Phase 2)WithdrawnNCT01750866
What this trial is testing

Cabazitaxel in Men 75 Years of Age or Older With Castration-Resistant Prostate Cancer

Who this might be right for
Castrate-resistant Metastatic Prostate Cancer
Case Comprehensive Cancer Center
Testing effectiveness (Phase 2)UnknownNCT03257891
What this trial is testing

Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy Lines

Who this might be right for
Adrenocortical Carcinoma
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 25
Testing effectiveness (Phase 2)Ended earlyNCT01941550
What this trial is testing

Neoadjuvant Chemotherapy With Cabazitaxel

Who this might be right for
High-Risk Cancer
RWTH Aachen University 11
Early research (Phase 1)WithdrawnNCT01981668
What this trial is testing

The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivation

Who this might be right for
Prostatic Neoplasms
Nova Scotia Cancer Centre
Next Page